# Mass Balance Study of [14C]HSK31858 in Healthy Adult Male Chinese Subjects.

> **NCT06569784** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Xizang Haisco Pharmaceutical Co., Ltd** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [14C]HSK31858

## Key facts

- **NCT ID:** NCT06569784
- **Lead sponsor:** Xizang Haisco Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-05-30
- **Primary completion:** 2024-07-02
- **Final completion:** 2024-10-30
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2024-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06569784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06569784, "Mass Balance Study of [14C]HSK31858 in Healthy Adult Male Chinese Subjects.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06569784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*